Articles, App Notes, Case Studies, & White Papers

31. Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch 4/22/2024

    The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.

32. One Day, We Won't Need Placebos 11/17/2023

    Embrace the future of clinical research by recognizing the limitations of traditional double-blind trials and exploring the transformative potential of real-world evidence (RWE).

33. How A Remote ePRO Solution Helped Reduce Patient Burden 9/19/2022

    Discover how transitioning multiple studies from on-site to at-home assessments improved patient retention and recruitment for a global neurology program.

34. One Day, Clinical Trials Will Represent The Real World 2/12/2024

    What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.

35. Medable Platform Delivers >90% eCOA Adherence And Scalability 7/8/2024

    Discover how eCOA use drove >90% adherence across an extensive weight management master protocol clinical trial with multiple sub-studies across 70+ research sites.

36. The FDA Just Rewrote The Rules For Clinical Trials. Here's What It Means For RTSM. 7/30/2026

    Learn how evolving trial designs are changing RTSM requirements and driving demand for greater flexibility, traceability, and execution quality.

37. Bridging Clinical Efficacy And Real-World Effectiveness In Digital Therapeutics Trials 2/7/2022

    No matter how conclusive clinical evidence is for medical treatments, developers may struggle to see precisely how their treatment performs in the real world—outside the controlled environment of the clinic or office.

38. Key Takeaways From The Recent FDA DCT Draft Guidance 8/7/2023

    Get an overview of draft perspectives and key points to reinforce decentralized clinical trial training, oversight, and risk assessment to guarantee a study's integrity, patient safety, and success.

39. Simplifying The Vineland-3: Assisting Raters, Reducing Burden, And Improving Data Quality 10/21/2024

    Electronic versions of both Vineland-II and Vineland-3 have been developed with features to improve data accuracy and consistency such as built-in prompts, item-specific scoring guidance, and automated calculations.

40. Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development 3/4/2026

    Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.